Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.20% | 10.90% | 7.24% | 1.47% | 6.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.20% | 10.90% | 7.24% | 1.47% | 6.94% |
| Cost of Revenue | 19.31% | 10.82% | 12.46% | -5.54% | 1.24% |
| Gross Profit | 11.22% | 10.95% | 4.30% | 6.09% | 10.55% |
| SG&A Expenses | 14.82% | 8.59% | 4.63% | -0.07% | 5.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.39% | 10.22% | 8.44% | -2.03% | 3.75% |
| Operating Income | 0.97% | 14.65% | 0.57% | 43.99% | 31.33% |
| Income Before Tax | 23.06% | 20.78% | 4.20% | 42.57% | 2.95% |
| Income Tax Expenses | -5.86% | 33.06% | 1.05% | 35.38% | 21.52% |
| Earnings from Continuing Operations | 32.78% | 17.33% | 5.22% | 44.90% | -2.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.76% | 173.64% | -72.03% | 419.51% | -1,965.00% |
| Net Income | 34.04% | 18.30% | 4.82% | 47.20% | -4.15% |
| EBIT | 0.97% | 14.65% | 0.57% | 43.99% | 31.33% |
| EBITDA | 17.10% | 12.75% | 0.37% | 22.33% | 33.65% |
| EPS Basic | 31.82% | 17.65% | 6.38% | 47.37% | -2.22% |
| Normalized Basic EPS | 22.13% | 21.32% | 5.41% | 45.22% | 2.52% |
| EPS Diluted | 31.82% | 17.65% | 6.38% | 47.37% | -2.22% |
| Normalized Diluted EPS | 22.13% | 21.32% | 5.41% | 45.22% | 2.52% |
| Average Basic Shares Outstanding | 1.68% | 0.55% | -1.47% | -0.11% | -1.97% |
| Average Diluted Shares Outstanding | 1.68% | 0.55% | -1.47% | -0.11% | -1.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |